0001722024-20-000003.txt : 20200611
0001722024-20-000003.hdr.sgml : 20200611
20200611202429
ACCESSION NUMBER: 0001722024-20-000003
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200611
FILED AS OF DATE: 20200611
DATE AS OF CHANGE: 20200611
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Alexandria Venture Investments, LLC
CENTRAL INDEX KEY: 0001722024
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39321
FILM NUMBER: 20958565
BUSINESS ADDRESS:
STREET 1: 26 NORTH EUCLID AVENUE
CITY: PASADENA
STATE: CA
ZIP: 91101
BUSINESS PHONE: 626-578-0777
MAIL ADDRESS:
STREET 1: 26 NORTH EUCLID AVENUE
CITY: PASADENA
STATE: CA
ZIP: 91101
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Avidity Biosciences, Inc.
CENTRAL INDEX KEY: 0001599901
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 461336960
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10975 N. TORREY PINES RD.,
STREET 2: #150
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: 858-401-7900
MAIL ADDRESS:
STREET 1: 10975 N. TORREY PINES RD.,
STREET 2: #150
CITY: LA JOLLA
STATE: CA
ZIP: 92037
FORMER COMPANY:
FORMER CONFORMED NAME: Avidity Biosciences LLC
DATE OF NAME CHANGE: 20161227
FORMER COMPANY:
FORMER CONFORMED NAME: Avidity NanoMedicines LLC
DATE OF NAME CHANGE: 20140211
3
1
wf-form3_159192144910391.xml
FORM 3
X0206
3
2020-06-11
0
0001599901
Avidity Biosciences, Inc.
RNA
0001722024
Alexandria Venture Investments, LLC
26 NORTH EUCLID AVENUE
PASADENA
CA
91101
0
0
1
0
Series A convertible preferred stock
Common stock
187248.0
D
Series B convertible preferred stock
Common stock
251536.0
D
Series C convertible preferred stock
Common stock
63581.0
D
The preferred stock is convertible into the Issuer's common stock at a ratio of 2.1095 shares of preferred stock to 1 share of common stock at the holder's election and has no expiration date. The preferred stock will automatically convert into common stock upon the closing of the Issuer's initial public offering, for no additional consideration.
Not applicable.
By: ALEXANDRIA REAL ESTATE EQUITIES, INC., a Maryland corporation, managing member
By: /s/ Dean A. Shigenaga
Chief Financial Officer
2020-06-11